Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma
一项针对切除的高危黑色素瘤患者的I/II期临床试验,评估长肽疫苗(LPV7)联合Toll样受体(TLR)激动剂,以及不联合不完全弗氏佐剂(IFA)的疗效。
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003220
Patel, Sapna P; Petroni, Gina R; Roszik, Jason; Olson, Walter C; Wages, Nolan A; Chianese-Bullock, Kimberly A; Smolkin, Mark; Varhegyi, Nikole; Gaughan, Elizabeth; Smith, Kelly T; Haden, Kathleen; Hall, Emily H; Gnjatic, Sacha; Hwu, Patrick; Slingluff, Craig L